Posted by Michael Wonder on 22 Dec 2022
Final report for the post-market review of medicines for smoking cessation and review outcomes
22 December 2022 - The final report for the post-market review of medicines for smoking cessation is now available. The final report includes the cost effectiveness review conducted under Term of Reference 4 of the review.
No substantive changes were made to the remaining sections of the final report from the previously published draft review report.
